City of Hope Leadership Team

Robert Stone is the award-winning chief executive officer at the helm of City of Hope's evolution into a world leader in cancer research, treatment and prevention. Under his strategic direction, City of Hope is accelerating opportunities for high-impact discovery and access to advanced therapies.

Kristin Bertell is the chief philanthropy officer at City of Hope who provides strategic leadership for all of its philanthropic efforts, executing a diverse portfolio of fundraising programs and activities.

John D. Carpten, Ph.D., Director of the Comprehensive Cancer Center and is uniquely positioned to help further City of Hope's critical goal of democratizing cancer care and expanding access to leading-edge research and care for more patients, families and communities.

David W. Craig, Ph.D., Associate Director for Data Science, Comprehensive Cancer Center and founding Chair and Deputy Director of Translational Sciences at the Beckman Research Institute of City of Hope.

Loretta Erhunmwunsee, M.D., F.A.C.S., is the Vice President and Chief Health Access and Community Enrichment Officer at City of Hope Medical Center where she leads the development and implementation of strategy that addresses health disparities and that fosters inclusion across the City of Hope

Debra Fields, executive vice president and chief transformation officer, leads the teams focused on accelerating City of Hope's impact through aligned organizational governance and design, progressive talent strategy, change navigation and integration methodology, and marketing and communications.

As president of City of Hope Chicago, Pete Govorchin, M.B.A., leads hospital operations and continuously seeks to expand access to innovative treatments for patients. He works closely with local government officials and community groups to expand access to oncology care in the Chicagoland area.

David Horne, Ph.D., vice provost and deputy director of Beckman Institute of the City of Hope and dean of Faculty Affairs, helps shape the scientific and educational vision of City of Hope with his research expertise in Medicinal Chemistry, Drug Development, and Molecular Medicine.

Vince Jensen, M.B.A., is the system chief executive of City of Hope's Medical Foundation and Physician Services, responsible for physician organization, overseeing the academic practice plan and other physician services across the system.

Harlan Levine, M.D., is president of health innovation and policy at City of Hope. He also serves as the chairman of the board of AccessHope™, a spinout company from City of Hope that is focused on serving the employer and payer markets and making leading-edge cancer care available to all regardless

Nisha Morris is senior vice president and chief marketing and communications officer at City of Hope, overseeing the strategy and implementation of all the organization's messaging and communications.

Vanessa Almendro Navarro, Ph.D., M.B.A., is the chief commercialization officer at City of Hope.

Simon Nazarian, system executive vice president and chief digital and technology officer, spearheads City of Hope's technology strategy, driving innovation through AI-driven digital capabilities and insight-driven advanced analytics.

Cristin O'Callahan is City of Hope's general counsel and corporate secretary, overseeing the departments responsible for legal matters, risk mitigation and ethics and compliance as well as serving as corporate secretary.

Angelique Richard, Ph.D., R.N., is a national leader in nursing, is the chief operating officer of City of Hope National Medical Center, LA, OC and the Southern California clinical network.

Steven T. Rosen, M.D., is a professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, and executive vice president and director emeritus, Comprehensive Cancer Center and Beckman Research Institute of City of Hope.

Joline Treanor is system chief human resources officer at City of Hope, where she is focused on creating an engaging workplace while ensuring that City of Hope has key strategies in place to accelerate a culture of performance excellence and continuous improvement.

Jeffrey M. Trent, Ph.D., is the president and research director of Translational Genomics Research Institute (TGen), which joined forces with City of Hope to accelerate the speed at which scientists and medical staff convert research discoveries into cures for patients.

Vijay Trisal, M.D., the Dr. Norman & Melinda Payson Professor in Medicine, is the system chief clinical officer responsible for setting the vision and direction for systemwide quality, patient safety, and developing guidelines for clinical pathways and protocols.

Marcel van den Brink is president of City of Hope Los Angeles and National Medical Center and serves as chief physician executive. A globally recognized leader in bone marrow transplantation and microbiome and cancer immunotherapy, he is widely respected for his collaborative leadership as well as

Annette M. Walker, president of City of Hope Orange County and Ronald & Sandi Simon Presidential Chair, drives the development and growth of a 21st-century comprehensive cancer campus in Irvine and a network of care that will provide Orange County residents unprecedented access to leading-edge